Imipramine does not affect argon-laser-induced pin-prick pain thresholds and laser-evoked cerebral potentials

European Journal of Pain

Volumn 2, Issue 2, 1998, Pages 127-132

  Sindrup, S H ^a   Nielsen, J C ^b   Bjerring, P ^b   Arendt Nielsen, L ^c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE;

ADULT; ANTINOCICEPTION; ARGON LASER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EVOKED CORTICAL RESPONSE; FEMALE; HEAT SENSATION; HUMAN; HUMAN EXPERIMENT; MALE; NEUROMODULATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PAIN THRESHOLD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN SENSITIVITY;

EID: 0031829466     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-3801(98)90005-2     Document Type: Article

References (26)

1. Arendt-Nielsen L, Bjerring P. Sensory and pain threshold characteristics to laser stimuli. J Neurol Neurosurg Psychiatry 1988; 51: 35-42.
2. Arendt-Nielsen L. First pain event related responses to argon laser stimuli - recording and quantification. J Neurol Neurosurg Psychiatry 1990; 53: 398-404.
3. Arendt-Nielsen L, Brennum J, Sindrup SH and Bak P. Electrophysiological and psychophysical quantification of temporal summation in the human nociceptive system. Eur J Applied Physiol 1994; 68: 266-273.
4. Arendt-Nielsen L, Petersen-Felix S, Fischer M, Bak P, Bjerring P, Zbinden AM. The effect of NMDA-antagonist (Ketamine) on central temporal summation - a double-blind placebo-controlled experimental human study. Anesth Analg 1995; 81: 63-68.
5. Arendt-Nielsen L, Nielsen JC, Bjerring P, Double-blind, placebo controlled comparison of paracetamol and paracetamol plus codeine - a quantitative evaluation by laser induced pain. Eur J Clin Pharmacol 1991; 40: 241-247.
6. Arendt-Nielsen L. Characteristics, detection, and modulation of laser-evoked vertex potentials. Acta Anaesth Scand 1994; 38 (Suppl. 98): 1-44.
7. Biegon A, Samuel D. Interaction of tricyclic antidepressants with opiate receptors. Biochem Pharmacol 1980; 29: 460-462.
8. Brennum J, Arendt-Nielsen L, Horn A, Secher NH, Jensen TS. Quantitative sensory examination in human epidural anaesthesia and analgesia: effects of morphine. Pain 1993; 52: 75-83.
9. Bromm B, Meier W, Scharein E. Imipramine reduces experimental pain. Pain 1986; 25: 245-257.
10. Brøsen K, Otton SV, Gram LF. Imipramine demethylation and hydroxylation: Impact of the sparteine oxidation phenotype. Clin Pharmacol Ther 1986; 40: 543-549.
11. Brøsen K, Gram LF. Clinical significance of the sparteine/ debrisoquine oxidation polymorphism. Eur J Clin Pharmacol 1989; 36: 537-547.
12. Cooper BY, Vierck CJJ, Yeomans DC. Selective reduction of second pain sensations by systemic morphine in humans. Pain 1986; 24: 93-116.
13. Coquoz D, Porchet HC, Dayer P. [Central analgesic effects of antidepressant drugs with various mechanisms of action: desipramine, fluvoxamine and moclobemide]. Schweiz Med Wochenschr 1991; 121: 1843-1845.
14. de Felipe MC, de Ceballos ML, Fuentes, JA. Hypoalgesia induced by antidepressants in mice: a case for opioids and serotonin. Eur J Pharmacol 1986; 125: 193-199.
15. Giardina E-GV, Bigger JT, Glassman AH, Perel JM, Kantor SJ. The electrocardiographic and anti arrhythmic effects of imipramine hydrocloride at therapeutic plasma concentrations. Circulation 1979; 60: 1045-1052.
16. Habuchi Y, Furukawa T, Tanaka H, Tsujimura Y, Yoshimura M. Block of Na + channels by imipramine in guinea pig cardiac ventricular cells. J Pharmacol Exp Ther 1991; 256: 1072-1081.
17. Isenberg KE, Cicero TJ. Possible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds. Eur J Pharmacol 1984; 103: 57-63.
18. Juan H. Inhibition of the algesic effect of bradykinin and acetylcholine by mepacrine. Naunyn Schmiedebergs Arch Pharmacol 1977; 301: 23-27.
19. Matthews JN, Altman DG, Campbell MJ, Royston P, Analysis of serial measurements in medical research. B M J 1990; 300: 230-235.
20. Nielsen JC, Bjerring P, Arendt-Nielsen L, Petterson K-J. A double-blind, placebo controlled, cross-over comparison of the analgesic effect of ibuprofen 400 mg and 800 mg on laser-induced pain. Br J Clin Pharmacol 1990; 30: 711-715.
21. Nielsen JC, Bjerring P, Arendt-Nielsen L. A comparison of the hypoalgesic effect of paracetamol in slow release and plain tablets on laser-induced pain. Br J Clin Pharmacol 1991a; 31: 267-279.
22. Nielsen JC, Arendt-Nielsen L, Bjerring P, Carlsson P. Analgesic efficay of low doses of intravenously administered lidocaine on experimental laser-induced pain: a placebo controlled study. Regional Anesthesia 1991b; 16: 28-33.
23. Poulsen L, Arendt-Nielsen L, Brøsen K, Nielsen KK, Gram LF, Sindrup SH. The hypoalgesic effect of imipramine in different human experimental pain models. Pain 1995; 60: 287-293.
24. Reichenberg K, Gaillard Plaza G, Montastruc JL. Influence of naloxone on the antinociceptive effects of some antidepressant drugs. Arch Int Pharmacodyn Ther 1985; 275: 78-85.
25. Sindrup SH. Antidepressants as analgesics. In: Yaksh TL, Lynch C, Zapol WM, Maze M, Biebuyck JF, Saidman LJ. editors. Anesthesia: Biological Foundations. Philadelphia: Lippencott-Raven Publishers, 1997: 987-997
26. van der Burght M, Rasmussen S E, Arendt-Nielsen L, Bjerring P. Morphine does not affect laser induced warmth and pin prick pain thresholds. Acta Anaesthesiol Scand 1994; 38: 161-164.